Skip to main content
. Author manuscript; available in PMC: 2010 Oct 9.
Published in final edited form as: J Mol Biol. 2009 Jul 1;392(5):1178–1191. doi: 10.1016/j.jmb.2009.06.064

Table 1.

Distribution of D-Ala in peptidoglycan of the drug-treated whole cells of E. faecium (mid-exponential growth) of Figures 3 and 7.

D-Ala-D-Asp [%] D-Ala-D-Ala [%] D-Ala [%]
No vancomycin* 76 24 0
15 μg/ml vancomycin 48 47 5
25 μg/ml vancomycin 45 48 7
No oritavancin 76 24 0
15 μg/ml oritavancin 83 17 0
25 μg/ml oritavancin 89 11 0
*

On the basis of three different growths, the relative concentrations are ±1 of those shown (e.g., 76 ±1%).